Talk:5F-ADB: Difference between revisions

(33 intermediate revisions by 6 users not shown)

Line 1:

~~5F-ADB (also known as 5F-MDMB-PINACA)~~ is ~~an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family, which has been used as an active ingredient~~ in ~~synthetic cannabis products and has been sold online as a designer drug. 5F-ADB is a potent agonist of~~ the ~~CB1 receptor, though~~ it is ~~unclear whether it~~ is ~~selective~~ for ~~this target~~. ~~5F-ADB was first identified in November 2014 from post-mortem samples taken from an individual who had died after using a product containing~~ this ~~substance. Subsequent testing identified 5F-ADB~~ to ~~have been present~~ in ~~a total~~ of ~~ten people who had died from unexplained drug overdoses in Japan between September 2014 and December 2014, and it was added to~~ the ~~Jap~~

{{decree|type=notice|message=This article is in the 'Talk' namespace because it is an unfinished draft. This section is used to host drafts for unpublished articles as well as discussions for published ones. If you'd like to use this area to discuss this draft, please do so in the 'Discussion' section at the very bottom of the page. This notice will be removed once this draft has been approved for publication by an administrator.}}

{|

{{headerpanel|{{approval}}{{stub}}}}

|-

| {{~~proofread~~}}

| {{~~Approval}~~}

|}

~~{{SubstanceBox/Example~~}}

~~==Chemistry==~~

5F-ADB (also known as 5F-MDMB-PINACA) is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family, which has been used as an active ingredient in synthetic cannabis products and has been sold online as a designer drug, there is also evidence of this product making it's way into the illicit cannabis market without the users knowing. 5F-ADB is a potent agonist of the CB1 receptor, though it is unclear whether it is selective for this target. 5F-ADB was first identified in November 2014 from post-mortem samples taken from an individual who had died after using a product containing this substance. Subsequent testing identified 5F-ADB to have been present in a total of ten people who had died from unexplained drug overdoses in Japan between September 2014 and December 2014, and it was added to the Jap

~~{{chemistry}}~~

~~==Pharmacology==~~

~~{{pharmacology}}~~

==~~Subjective effects~~==

==External links==

~~{{EffectStub}}~~

*[[wikipedia:5F-ADB|5F-ADB (Wikipedia)]]

~~==Toxicity and harm potential==~~

*[https://isomerdesign.com/PiHKAL/explore.php?id=4499 5F-ADB (Isomer Design)]

~~It is strongly recommended that one use~~ [[~~responsible use~~|~~harm reduction practices~~]] ~~when using this drug.~~

https://www.wedinos.org/db/samples/search/THC%20E-juice

~~===Lethal dosage===~~

[[Category:Psychoactive substance]]

~~===Tolerance and addiction potential===~~

[[Category:Stub]]

[[Category:Articles in talk page]]

~~==Legal issues==~~

~~{{LegalStub}}~~

~~==See also==~~

*[~~[Responsible use]~~]

~~==References==~~

~~<references~~ />

~~{{references}}~~

[[Category:~~Substance~~]][[Category:~~Psychoactive substance~~]][[Category:~~Proofread~~]]

~~anese banned drug list in December 2014.~~

@@ Line 1: / Line 1: @@
-F-ADB (also known as 5F-MDMB-PINACA) is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family, which has been used as an active ingredient in synthetic cannabis products and has been sold online as a designer drug. 5F-ADB is a potent agonist of the CB1 receptor, though it is unclear whether it is selective for this target. 5F-ADB was first identified in November 2014 from post-mortem samples taken from an individual who had died after using a product containing this substance. Subsequent testing identified 5F-ADB to have been present in a total of ten people who had died from unexplained drug overdoses in Japan between September 2014 and December 2014, and it was added to the Jap
+{{decree|type=notice|message=This article is in the 'Talk' namespace because it is an unfinished draft. This section is used to host drafts for unpublished articles as well as discussions for published ones. If you'd like to use this area to discuss this draft, please do so in the 'Discussion' section at the very bottom of the page. This notice will be removed once this draft has been approved for publication by an administrator.}}
-{|
+{{headerpanel|{{approval}}{{stub}}}}
-|-
-|-
-| {{proofread}}
-| {{Approval}}
-|}
-{{SubstanceBox/Example}}
-==Chemistry==
+F-ADB (also known as 5F-MDMB-PINACA) is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family, which has been used as an active ingredient in synthetic cannabis products and has been sold online as a designer drug, there is also evidence of this product making it's way into the illicit cannabis market without the users knowing. 5F-ADB is a potent agonist of the CB1 receptor, though it is unclear whether it is selective for this target. 5F-ADB was first identified in November 2014 from post-mortem samples taken from an individual who had died after using a product containing this substance. Subsequent testing identified 5F-ADB to have been present in a total of ten people who had died from unexplained drug overdoses in Japan between September 2014 and December 2014, and it was added to the Jap
-{{chemistry}}
-==Pharmacology==
-{{pharmacology}}
-==Subjective effects==
+==External links==
-{{EffectStub}}
+*[[wikipedia:5F-ADB|5F-ADB (Wikipedia)]]
-==Toxicity and harm potential==
+*[https://isomerdesign.com/PiHKAL/explore.php?id=4499 5F-ADB (Isomer Design)]
-It is strongly recommended that one use [[responsible use|harm reduction practices]] when using this drug.
+https://www.wedinos.org/db/samples/search/THC%20E-juice
-===Lethal dosage===
+[[Category:Psychoactive substance]]
-===Tolerance and addiction potential===
+[[Category:Stub]]
+[[Category:Articles in talk page]]
-==Legal issues==
-{{LegalStub}}
-==See also==
-*[[Responsible use]]
-==References==
-<references />
-{{references}}
-[[Category:Substance]][[Category:Psychoactive substance]][[Category:Proofread]]
-anese banned drug list in December 2014.